The Third Xiang-Ya Hospital, Central South University, Changsha, China.
Cancer Gene Ther. 2015 Apr;22(3):145-53. doi: 10.1038/cgt.2014.80. Epub 2015 Jan 23.
Human epidermal growth factor receptor-2 (HER-2) overexpression was closely associated with the tumor growth and invasion, we here aimed to investigate the mechanism of HER-2 mediation in the pathogenesis of gastric cancer (GC). We first detected the expression of HER-2 in GC cell line SGC-7901 and then examined the levels of nuclear factor-κB (NF-κB), matrix metalloproteinase-9 (MMP-9) and intercellular adhesion molecule-1 (ICAM-1) and the association between them by molecular methods. Statistical analysis was used to compare the significance. We further detected the possible molecular mechanism involved in their relationship in the SGC-7901 genesis. The MMP-9, NF-κB and secretory type (s-ICAM-1) levels were significantly greater in peripheral blood serum from SGC-7901 than healthy control GES-1 (P<0.01). ICAM-1, MMP-9 and NF-κB mRNA and protein levels were more highly expressed in SGC-7901 than healthy control GES-1. The expression levels of NF-κB, MMP-9 and ICAM-1 were positively related in GC cell line SGC-7901, which was HER-2 positive. The HER-2 positive SGC-7901 secreted more transforming growth factor beta 1 (TGF-β1) and resultantly activated MMP-9 to enhance s-ICAM-1 secretion and further studies showed that phosphatidylinositol-3 kinase (PI3K)/Akt/NF-κB signaling pathway was involved in GC pathogenesis. The GC cells that express the HER-2 oncogene spur the activation of NF-κB that can upregulate the expression of ICAM-1 and induce the expression of MMP-9, which hydrolyzes ICAM-1 into s-ICAM-1 to promote tumor immune escape. TGF-β1-induced PI3K/Akt/NF-κB signaling pathway was involved in the pathogenesis of GC and they could be a new target for cancer therapy. The GC cells that express the HER-2 oncogene spur the activation of NF-κB that can upregulate the expression of ICAM-1 and induce the expression of MMP-9, which hydrolyzes ICAM-1 into s-ICAM-1 to promote tumor immune escape. TGF-β1-induced PI3K/Akt/NF-κB signaling pathway was involved in the pathogenesis of GC and they could be a new target for cancer therapy.
人表皮生长因子受体 2(HER-2)过表达与肿瘤的生长和侵袭密切相关,本研究旨在探讨 HER-2 在胃癌(GC)发病机制中的作用机制。我们首先检测了 GC 细胞系 SGC-7901 中 HER-2 的表达,然后通过分子方法检测了核因子-κB(NF-κB)、基质金属蛋白酶-9(MMP-9)和细胞间黏附分子-1(ICAM-1)的水平及其之间的关系。统计分析用于比较显著性。我们进一步检测了 SGC-7901 起源中涉及它们关系的可能分子机制。与健康对照 GES-1 相比,SGC-7901 外周血清中 MMP-9、NF-κB 和分泌型(s-ICAM-1)水平显著升高(P<0.01)。与健康对照 GES-1 相比,SGC-7901 中 ICAM-1、MMP-9 和 NF-κB mRNA 和蛋白表达水平更高。GC 细胞系 SGC-7901 中 NF-κB、MMP-9 和 ICAM-1 的表达水平呈正相关,该细胞系为 HER-2 阳性。HER-2 阳性 SGC-7901 分泌更多的转化生长因子β1(TGF-β1),从而激活 MMP-9 增强 s-ICAM-1 的分泌,进一步研究表明,磷脂酰肌醇-3 激酶(PI3K)/Akt/NF-κB 信号通路参与 GC 的发病机制。表达 HER-2 癌基因的 GC 细胞刺激 NF-κB 的激活,NF-κB 可以上调 ICAM-1 的表达,并诱导 MMP-9 的表达,MMP-9 将 ICAM-1 水解为 s-ICAM-1 以促进肿瘤免疫逃逸。TGF-β1 诱导的 PI3K/Akt/NF-κB 信号通路参与 GC 的发病机制,可能成为癌症治疗的新靶点。表达 HER-2 癌基因的 GC 细胞刺激 NF-κB 的激活,NF-κB 可以上调 ICAM-1 的表达,并诱导 MMP-9 的表达,MMP-9 将 ICAM-1 水解为 s-ICAM-1 以促进肿瘤免疫逃逸。TGF-β1 诱导的 PI3K/Akt/NF-κB 信号通路参与 GC 的发病机制,可能成为癌症治疗的新靶点。